Influenza vaccines prepared from viruses with the potential to cause a pandemic and intended for use outside of the core dossier context - Scientific guideline
Table of contents
This document addresses the non-clinical and clinical dossier requirements, and post-authorisation issues for influenza vaccines. It applies to medicinal products prepared from viruses with a pandemic potential that are intended for use outside of the context of a core dossier.
The quality reguirements of this guideline have been replaced by the guideline on influenza vaccines - quality module.
Keywords: Pandemic influenza vaccines for human use, strains with pandemic potential, quality, non-clinical and clinical requirements
-
List item
Guideline on influenza vaccines prepared from viruses with the potential to cause a pandemic and intended for use outside of the core dossier context (PDF/199.64 KB)
Adopted
First published: 24/01/2007
Last updated: 24/01/2007
Legal effective date: 01/02/2007
EMEA/CHMP/VWP/263499/2006 -
List item
Draft guideline on dossier structure and content of marketing authorisation applications for influenza vaccines with avian strains with a pandemic potential for use outside of the core dossier context (PDF/226.46 KB)
Draft: consultation closed
First published: 24/07/2006
Last updated: 24/07/2006
EMEA/CHMP/VWP/263499/2006